BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
32 hedge funds and large institutions have $6.72M invested in BRAINSTORM CELL THERAPUTC in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.27% less ownership
Funds ownership: 0.85% → 0.58% (-0.27%)
27% less capital invested
Capital invested by funds: $9.23M → $6.72M (-$2.51M)
Holders
32
Holding in Top 10
–
Calls
$289K
Puts
$159K
Top Buyers
| 1 | +$206K | |
| 2 | +$148K | |
| 3 | +$95K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$94K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$84.3K |
Top Sellers
| 1 | -$2.76M | |
| 2 | -$471K | |
| 3 | -$70K | |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$25K |
| 5 |
BlackRock
New York
|
-$6.74K |